Dr. Simpkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# B
Philadelphia, PA 19104Phone+1 215-662-3318Fax+1 215-349-5849
Summary
- Dr. Fiona Simpkins is an obstetrician/gynecologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Pennsylvania Hospital. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 18 years. She specializes in gynecologic oncology and is experienced in fallopian tube carcinoma, gynecologic oncology, and cervical cancer. She has more than 50 publications and over 500 citings.
Education & Training
- Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1999 - 2003
- Lewis Katz School of Medicine at Temple UniversityClass of 1999
- Cleveland Clinic FoundationFellowship, Gynecologic Oncology
Certifications & Licensure
- FL State Medical License 2008 - 2024
- PA State Medical License 2013 - 2024
- OH State Medical License 2005 - 2010
- MD State Medical License 2003 - 2009
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer Start of enrollment: 2018 Mar 09
Publications & Presentations
PubMed
- [F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status.Joanna K Weeks, Austin R Pantel, Sarah B Gitto, Fang Liu, Erin K Schubert
Journal of Nuclear Medicine. 2024-12-05 - Geographic Disparities in Gynecologic Oncology Clinical Trial Availability in the US.Mary Regina Boland, Elizabeth Tubridy, Sebastian Spataro Solorzano, Fiona Simpkins, Anna Jo Bodurtha Smith
JAMA Network Open. 2024-11-04 - Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis.Anna Jo Bodurtha Smith, Sebastian Spataro, Jonathan Heintz, Fiona Simpkins, Emily M Ko
American Journal of Obstetrics and Gynecology. 2024-09-28
Journal Articles
- Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-like CellsFiona Simpkins, MD, Clinical Cancer Research
Press Mentions
- Penn Medicine at the AACR Annual Meeting 2023April 7th, 2023
- Analysis Reveals Genomic Effects of a New Cancer Treatment Now in Clinical TrialsOctober 3rd, 2018
- PARP-1 May Be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image ItApril 27th, 2018
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: